Curdlan sulphate modulates protein synthesis and enhances NF-κB and C/EBP binding activity in HepG2 cells

Mediators of Inflammation

Volumn 6, Issue 1, 1997, Pages 58-63

  Guzdek, A ^a   Rokita, H ^a  

^a JAGIELLONIAN UNIVERSITY   (Poland)

Author keywords

C EBP; Curdlan sulphate; MnSOD mRNA; NF B; Serum protein synthesis

Indexed keywords

CERULOPLASMIN; CHYMOTRYPSIN INHIBITOR; CURDLAN; FIBRINOGEN; INTERLEUKIN 6; MANGANESE SUPEROXIDE DISMUTASE; MESSENGER RNA; TRANSCRIPTION FACTOR; TRANSFERRIN;

ARTICLE; CELL LINE; HEPATOMA CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN SYNTHESIS;

EID: 0031041424     PISSN: 09629351     EISSN: None     Source Type: Journal    
DOI: 10.1080/09629359791947     Document Type: Article

References (45)

1. Chihara G. Immunopharmacology of lentinan a polysaccharide isolated from Lentinus edodes: its application as a host defence potentiator. Int J Oriental Med 1992; 17: 57-77.
2. Nemoto J, Ohno N, Saito K, Adachi Y, Yadomae T. Expression of interleukin 1 family mRNAs by a highly branched (1 → 3)-β-D-glucan, OL-2. Biol Pharm Bull 1993; 16: 1046-1050.
3. Adachi Y, Okazaki M, Ohno N, Yadomae T. Enhancement of cytokine production by macrophages stimulated with (1 → 3)-β-D-glucan, grifolan (GRN), isolated from Grifolia frondosa. Biol Pharm Bull 1994; 17: 1554-1560.
4. Yoshida I, Kiho T, Usui S, Sakushima M, Ukai S. Polysaccharides in fungi. 37. Immunomodulating activities of carboxymethylated derivatives of linear ( 1 → 3)-alpha-D-glucans extracted from the fruiting bodies of Agrocybe cylindracea and Amanita muscuria. Biol Pharm Bull 1996; 19: 114-121.
5. Suzuki M, Takatsuki F, Maeda YY, Hamuro J, Chihara G. Lentinan. Rationale for development and therapeutic potential. Clin Immunother 1994; 2: 121-133.
6. Morinaga H, Tazawa K, Tagoh H, Muraguchi A, Fujimaki M. An in vivo study of hepatic and splenic interleukin-1 beta mRNA expression following oral PSK or LEM administration. Jpn J Cancer Res 1994; 85: 1298-1303.
7. Maeda YY, Yonekawa H, Chihara G. Application of lentinan as cytokin inducer and host defense potentiator in immunotherapy of infectious diseases. In: Masihi N, ed. Immunotherapy of Infections New York, Basel, Hong Kong: M. Dekker, 1994; 261-279.
8. Szabo T, Kadish JL, Czop JK. Biochemical properties of the ligand-binding 20-kDa subunit of the β-glucan receptors on human mononuclear phagocytes. J Biol Chem 1995; 270: 2145-2151.
9. Thornton BP, Vetvicka V, Pitman M, Goldman RC, Ross GD. Analysis of the sugar specificity and molecular location of the β-glucan-binding lectin site of complement receptor type 3 (CD11b/CD18). J Immunol 1996; 156: 1235-1246.
10. Muller A, Rice PJ, Ensley HE, Coogan PS, Kalbfleisch JH, Kelly JL, et al. Receptor binding and internalization of water-soluble (1 → 3)-β-D-glucan biologic response modifier in two monocyte/macrophage cell lines. J Immunol 1996; 156: 3418-3425.
11. Duan XM, Ackerly E, Vivier E, Anderson P. Evidence for involvement of β-glucan-binding cell surface lectins in human natural killer cell function. Cell Immunol 1994; 157: 393-398.
12. Muller CD, Bocchini V, Giaimis J, Guerrieri P, Lombard Y, Poindron P. Functional beta-glucan receptor expression by a microglial cell line. Res Immunol 1994; 145: 267-275.
13. Tapper H, Sundler R. Glucan receptor and zymosan-induced lysosomal enzyme secretion in macrophages. Biochem J 1995; 306: 829-835.
14. Okazaki M, Adachi Y, Ohno N, Yadomae T. Structure-activity relationship of (1 → 3)-beta-D-glucans in the induction of cytokine production from macrophages, in vitro. Biol Pharm Bull 1995; 18: 1320-1327.
15. Okazaki M, Chiba N, Adachi Y, Ohno N. Signal transduction pathway on β-glucans-triggered hydrogen peroxide production by murine peritoneal macrophages in vitro. Biol Pharm Bull 1996; 19: 18-23.
16. Franz G, Alban S. Structure-activity relationship of antithrombotic polysaccharide derivatives. Int J Macromol 1995; 17: 311-314.
17. Alban S, Jeske W, Wetzel D, Franz G, Fareed J. Anticoagulant and antithrombotic actions of a semisynthetic beta-1,3-glucan sulfate. Thromb Res 1995; 78: 201-210.
18. Konopski Z, Fandrem J, Seljelid R, Eskeland T. Interferon-gamma inhibits endocytosis of soluble aminated beta-1,3-D-glucan and neutral red in mouse peritoneal macrophages. J Interferon Cytokine Res 1995; 15: 579-603.
19. Yamamoto N, Nagashima H, Yoshida O, Kaneko Y, Matsuzaki K, Uryu T. Effect of the sulfated polysaccharides on HIV: a novel strategy of chemical modification for HIV antivirals Arch AIDS 1988; 1: 45-56.
20. Jagodzinski PP, Wiaderkiewicz R, Kurzawski G, Kloczewiak M, Nakashima H, Hyjek E, et al. Mechanism of the inhibitory effect of curdlan sulphate on HIV-1 infection in vitro. Virology 1994; 202: 735-745.
21. Gordon M, Guralnik M, Kaneko Y, Mimura T, Baker M. Lang W. A phase I study of curdlan sulphate - an HIV inhibitor. Tolerance, pharmacocinetics and effects on coagulation and on CD4 lymphocytes. J Med 1994; 25: 163-180.
22. Gordon M, Guralnik M, Kaneko Y, Mimura T, Goodgame J, Lang W. Further clinical studies of curdlan sulphate (CRDS) an anti HIV agent. J Med 1995; 26: 97-131.
23. Alban S, Franz G. Gas liquid chromatography-mass spectrometry analysis of anticoagulant active curdlan sulfate. Semin Thromb Hemost 1994; 20: 152-158.
24. Kanke M, Katayama H, Nakamura M. Application of curdlan to controlled drug delivery. Biol Pharm Bull 1995; 18: 1104-1108, 1154-1158.
25. Koj A, Gauldie J, Sweeney GD, Regoeczi E, Sauder DN. The acute phase response of cultured rat hepatocytes. System characterization and the effect of human cytokines. Biochem J 1984; 224: 505-515.
26. Rose-John S, Dietrich A, Marks F. Molecular cloning of mouse protein kinase C (PKC) cDNA from Swiss 3T3 fibroblasts. Gene 1988; 74: 465-471.
27. Feinberg AP, Vogelstein B. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activities. Analyt Biochem 1983; 132: 6-13.
28. Suzuki YJ, Mizuno M, Packer L. Signal transduction for nuclear factor-κB activation. Proposed location of antioxidant-inhibitable step. J Immunol 1994; 153: 5008-5015.
29. Duyao MP, Buckler AJ, Sonenshein GE. Interaction of an NK-κB-like factor with a site upstream of the c-myc promoter. Proc Natl Acad Sci 1990; 87: 4727-4731.
30. Maire P, Wuarin J, Schibler U. The role of cis-acting promoter elements in tissue-specific albumin gene expression. Science 1989; 244: 343-345.
31. Koj A, Korzus E, Haumann H, Nakamura T, Travis J. Regulation of synthesis of some proteinase inhibitors in human hepatoma cells by cytokines, hepatocyte growth factor and retinoic acid. Biol Chem Hoppe-Seyler 1993; 374: 193-201.
32. Malawista SE, Van Damme J, Sipe JD, Duff GW, Weiss MC. Independent effects of interleukin-6 (IL-6) and interleukin-1 (IL-1) on accumulation of specific mRNA for fibrinogen and for serum amyloid A in human hepatoma (HepG2) cells. Ann NY Acad Sci 1989; 557: 518-520.
33. Rokita H, Bartle L, Sipe J. Differential effect of interleukin-1 on interleukin-6-stimulated alpha-1-antichymotrypsin expression in human hepatoma cell lines. Folia Histochem Cytobiol 1992; 30: 161-164.
34. Sehgal PB, Wang L, Rayanade R, Pan H, Margulies L. Interleukin-6-type cytokines. Ann NY Acad Sci 1995; 762: 1-14.
35. Koj A. The role of interleukin-6 as the hepatocyte stimulating factor in the network of inflammatory cytokines. Ann NY Acad Sci 1989; 557: 1-8.
36. Kopf M, Ramsay A, Brombacher F, Baumann H, Freer G, Galanos Ch, Gutierrez-Ramos J-C, Kohler G. Pleiotropic defects of IL-6-deficient mice including early hematopoiesis, T and B cell function, and acute phase responses. Ann NY Acad Sci 1995; 762: 308-318.
37. Liao W S-L, Lu S-Y, Huang J, Li L, Bing Z. Transcription factors as targets of cytokine signals. Ann NY Acad Sci 1995; 762: 238-251.
38. Chen H-M, Liao WSL. Differential acute-phase response of rat kininogen genes involves type I and type II interleukin-6 response elements. J Biol Chem 1993; 268: 25311 -25319.
39. Mizuguchi J, Hu Ch-H, Cao Z, Loeb KR, Chung DW, Davie EW. Characterization of the 5′-flanking region of the gene for the γ chain of human fibrinogen. J Biol Chem 1995; 270: 28350-28356.
40. Shimizu H, Yamamoto K. NF-kappa B and C/EBP transcription factor families synergistically function in mouse serum amyloid A gene expression induced by inflammatory cytokines. Gene 1994; 149: 305-310.
41. Maeda Y, Chihara Y, Ishimura K. Unique increase of serum proteins and action of antitumor polysaccharides. Nature 1974; 252: 250-252.
42. Maeda Y, Takahama S, Kohara Y, Yonekawa H. Two genes controlling acute phase responses by the antitumor polysaccharide, lentinan. Immunogenetics 1996; 43: 215-219.
43. Fridovich I. Superoxide radical and superoxide dismutases. Annu Rev Biochem 1995; 64: 97-112.
44. Wan XS, Devalaraja MN, StClair DK. Molecular structure and organization of the human manganese superoxide dismutase gene. DNA Cell Biol 1994; 13: 1127-1136.
45. Borello S, DeLeo ME, Landriscina M, Palazzotti B, Galeotti T. Diethyldithiocarbamate treatment up regulates manganese superoxide dismutase gene expression in rat liver. Biochem Biophys Res Commun 1996; 220: 546-552.